ERBB3 and multiple sclerosis: The difference in the age of onset is remarkable when comparing individuals I4-40 and I4-41, which carried the three deletions in ERBB3. The importance of finding biomarkers for understanding the prognosis, outcomes, and therapeutic response of other complex diseases in early-onset individuals, such as multiple sclerosis, has been demonstrated [42].